Dynamic transmission modeling: A report of the ISPOR-SMDM modeling good research practices task force-5

Value in Health

Volumn 15, Issue 6, 2012, Pages 828-834

  Pitman, Richard ^a   Fisman, David ^b   Zaric, Gregory S ^c   Postma, Maarten ^d   Kretzschmar, Mirjam ^e   Edmunds, John ^f   Brisson, Marc ^g  

^a ICON PLC   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g LAVAL UNIVERSITY   (Canada)

Author keywords

best practices; dynamic transmission; infectious disease; modeling

Indexed keywords

ARTICLE; CHLAMYDIASIS; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; INFECTION; MALARIA; MEDICAL RESEARCH; MODEL; NONHUMAN; PAPILLOMAVIRUS INFECTION; PARASITE TRANSMISSION; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; VACCINATION;

ADVISORY COMMITTEES; COMPARATIVE EFFECTIVENESS RESEARCH; DISEASE TRANSMISSION, INFECTIOUS; EVIDENCE-BASED PRACTICE; HUMANS; MODELS, THEORETICAL; PRACTICE GUIDELINES AS TOPIC; SOFTWARE; UNCERTAINTY;

EID: 84866434292     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.06.011     Document Type: Article

References (65)

1. J.J. Caro, A.H. Briggs, U. Siebert Modeling good research practices - overview: A report of the ISPOR-SMDM modeling good research practices task force-1 Value Health 15 2012 796 803
2. M. Roberts, L. Russel, A.D. Paltiel Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2 Value Health 15 2012 804 811
3. U. Siebert, O. Alagoz, A.M. Bayoumi State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3 Value Health 15 2012 812 820
4. J. Karnon, J. Stahl, A. Brennan Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4 Value Health 15 2012 821 827
5. A.H. Briggs, M. Weinstein, E. Fenwick Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6 Value Health 15 2012 835 842
6. D.M. Eddy, W. Hollingworth, J.J. Caro Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7 Value Health 15 2012 843 850
7. M. Brisson, W.J. Edmunds Economic evaluation of vaccination programs: the impact of herd-immunity Med Decis Making 23 2003 76 82
8. M. Brisson, W.J. Edmunds Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs Med Decis Making 26 2006 434 446
9. S.Y. Kim, S.J. Goldie Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches Pharmacoeconomics 26 2008 191 215
10. T.E. Roberts, S. Robinson, P. Barton Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling Sex Transm Infect 82 2006 193 200
11. M. Kretzschmar, J. Wallinga Mathematical models in infectious disease epidemiology A. Kramer, M. Kretzschmar, K. Krickenberg, Modern Infectious Disease Epidemiology 2009 Springer New York
12. R.M. Anderson, R.M. May Infectious Diseases of Humans: Dynamics and Control 1991 Oxford University Press New York
13. T. Jelinek TropNetEurop Imported falciparum malaria in Europe: 2007 data from TropNetEurop Euro Surveill 13 2008 pii=18895 http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=18895 [Accessed June 26, 2012]
14. S.W. Lindsay, D.G. Hole, R.A. Hutchinson Assessing the future threat from vivax malaria in the United Kingdom using two markedly different modelling approaches Malar J 9 2010 70
15. M. Lipsitch, T. Cohen, B. Cooper Transmission dynamics and control of severe acute respiratory syndrome Science 300 2003 1966 1970
16. M. Lipsitch Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae Emerg Infect Dis 5 1999 336 345
17. M. Lipsitch Vaccination against colonizing bacteria with multiple serotypes Proc Natl Acad Sci U S A 94 1997 6571 6576
18. M. Brisson, W.J. Edmunds, N.J. Gay Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV J Med Virol 70 Suppl 2003 S31 S37
19. C. Claes, R.R. Reinert, J.M. von der Schulenburg Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects Eur J Health Econ 10 2009 25 38
20. A. Bergman, J. Hjelmgren, A. Ortqvist Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden Scand J Infect Dis 40 2008 721 729
21. D. Walker, P. Beutels Initiative for Vaccine Research WHO Guide for Standardization of Economic Evaluations of Immunization Programmes (Contract No. WHO/IVB/08.14) 2008 World Health Organization Geneva http://www.who.int/ vaccines-documents/ [Accessed July 3, 2011]
22. R. Welte, M. Postma, R. Leidl, M. Kretzschmar Costs and effects of chlamydial screening: dynamic versus static modeling Sex Transm Dis 32 2005 474 483
23. D.N. Fisman, C.V. Spain, M.E. Salmon, M. Goldberg The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling Sex Transm Dis 35 2008 S61 S65
24. A.P. Galvani, T.C. Reluga, G.B. Chapman Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum Proc Natl Acad Sci U S A 104 2007 5692 5697
25. M. Brisson, W.J. Edmunds, N.J. Gay Modelling the impact of immunization on the epidemiology of varicella zoster virus Epidemiol Infect 125 2000 651 669
26. J.J. Berge, D.P. Drennan, R.J. Jacobs The cost of hepatitis A infections in American adolescents and adults in 1997 Hepatology 31 2000 469 473
27. J.D. Fine, K.A. Arndt The TORCH syndrome: a clinical review J Am Acad Dermatol 12 1985 697 706
28. Centers for Disease Control and Prevention Measles, rubella, and congenital rubella syndrome - United States and Mexico, 1997-1999 MMWR Morb Mortal Wkly Rep 49 2000 1048 1050
29. T. Panagiotopoulos, I. Antoniadou, E. Valassi-Adam Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review BMJ 319 1999 1462 1467
30. W.J. Edmunds, M. Brisson The effect of vaccination on the epidemiology of varicella zoster virus J Infect 44 2002 211 219
31. M. Brisson, W.J. Edmunds, N.J. Gay, E. Miller Varicella vaccine and shingles JAMA 287 2002 2211
32. W.J. Edmunds, G.F. Medley, D.J. Nokes Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective Stat Med 18 1999 3263 3282
33. M. Lipsitch, C.T. Bergstrom, B.R. Levin The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions Proc Natl Acad Sci U S A 97 2000 1938 1943
34. H.J. Adam, S.E. Richardson, F.B. Jamieson Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination Vaccine 28 2010 4073 4078
35. W.P. Hanage, S.S. Huang, M. Lipsitch Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era J Infect Dis 195 2007 347 352
36. M.H. Samore, M. Lipsitch, S.C. Alder Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations Am J Epidemiol 163 2006 160 170
37. M. Jit, M. Brisson Modelling the epidemiology of infectious diseases for decision analysis: a primer Pharmacoeconomics 29 2011 371 386
38. S.Y. Kim, S.J. Goldie Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches Pharmacoeconomics 26 2008 191 215
39. N. Van de Velde, M. Brisson, M.C. Boily Understanding differences in predictions of HPV vaccine effectiveness: a comparative model-based analysis Vaccine 28 2010 5473 5484
40. M. Ajelli, B. Goncalves, D. Balcan Comparing large-scale computational approaches to epidemic modeling: agent-based versus structured metapopulation models BMC Infect Dis 10 2010 190
41. E. Brooks-Pollock, T. Cohen, M. Murray The impact of realistic age structure in simple models of tuberculosis transmission PLoS One 5 2010 e8479
42. L. Perez, S. Dragicevic An agent-based approach for modeling dynamics of contagious disease spread Int J Health Geogr 8 2009 50
43. P. Beutels, P.A. Scuffham, C.R. MacIntyre Funding of drugs: do vaccines warrant a different approach? Lancet Infect Dis 8 2008 727 733
44. A.J. van Hoek, A. Melegaro, N. Gay The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom Vaccine 30 2012 1225 1234
45. A.M. Foss, P.T. Vickerman, Z. Chalabi Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty Bull Math Biol 71 2009 720 749
46. M. Jit, N. Demarteau, E. Elbasha Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models BMC Med 9 2011 54
47. R.C. Brunham, B. Pourbohloul, S. Mak The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection J Infect Dis 192 2005 1836 1844
48. D.M. Vickers, N.D. Osgood Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling BMC Infect Dis 10 2010 70
49. G.F. Medley, N.A. Lindop, W.J. Edmunds, D.J. Nokes Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control Nat Med 7 2001 619 624
50. J.C. Heijne, C.L. Althaus, S.A. Herzog The role of reinfection and partner notification in the efficacy of chlamydia screening programs J Infect Dis 203 2011 372 377
51. M. van Boven, F.R. Mooi, J.F. Schellekens Pathogen adaptation under imperfect vaccination: implications for pertussis Proc Biol Sci 272 2005 1617 1624
52. C. Fraser, S. Riley, R.M. Anderson, N.M. Ferguson Factors that make an infectious disease outbreak controllable Proc Natl Acad Sci U S A 101 2004 6146 6151
53. R.M. Anderson, R.M. May Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes J Hyg (Lond) 94 1985 365 436
54. E. Zagheni, F.C. Billari, P. Manfredi Using time-use data to parameterize models for the spread of close-contact infectious diseases Am J Epidemiol 168 2008 1082 1090
55. A.M. Johnson, C.H. Mercer, B. Erens Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours Lancet 358 2001 1835 1842
56. M.E. Halloran, I.M. Longini Jr., C.J. Stuchiner Assessing indirect, total, and overall effects M.E. Halloran, I.M. Longini Jr. C.J. Stuchiner, Design and Analysis of Vaccine Studies 2010 Springer New York
57. M.P. Saccomani An effective automatic procedure for testing parameter identifiability of HIV/AIDS models Bull Math Biol 73 2011 1734 1753
58. Pandemic Influenza Outbreak Research Modelling Team (Pan-InfORM) D. Fisman Modelling an influenza pandemic: a guide for the perplexed CMAJ 181 2009 171 173
59. S.M. Moghadas, N.J. Pizzi, J. Wu Canada in the face of the 2009 H1N1 pandemic Influenza Other Respi Viruses 5 2011 83 88
60. T.G. van Rossum, H.E. de Melker, H. Houweling [Vaccines against human papillomavirus (HPV): between registration and implementation] Ned Tijdschr Geneeskd 152 2008 987 992
61. M.E. Halloran, N.M. Ferguson, S. Eubank Modeling targeted layered containment of an influenza pandemic in the United States Proc Natl Acad Sci U S A 105 2008 4639 4644
62. R. Hutubessy, A.M. Henao, P. Namgyal Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal BMC Med 9 2011 55
63. J. Mossong, N. Hens, M. Jit Social contacts and mixing patterns relevant to the spread of infectious diseases PLoS Med 5 2008 e74
64. K.A. Fenton, C. Korovessis, A.M. Johnson Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection Lancet 358 2001 1851 1854
65. R.L. Burden, J.D. Faires Numerical Analysis 4th ed. 1989 PWS-Kent Publishing Company Boston